Pharmacokinetic (PK) Bioequivalence and Pharmacodynamics (PD) of Julphar Insulin 30/70 and Huminsulin® Profil III

NCT02631928 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

73

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus

Interventions

DRUG: human biphasic insulin
DRUG: human biphasic insulin, reference

Sponsor

Julphar Gulf Pharmaceutical Industries

Collaborators

[object Object]